Fetal surgery is a constantly evolving field that showed noticeable progress with the treatment of myelomeningocele (MMC) using prenatal repair. Despite this success, there are ongoing questions regarding the optimal approach for fetal myelomeningocele repair, as well as which patients are eligible. Expansion of the inclusion and exclusion criteria is an important ongoing area of study for myelomeningocele including the recent Management of Myelomeningocele Plus trial. The significant personal and financial burden required of families seeking treatment has likely limited its accessibility to the general population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clp.2021.11.015 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!